Sign in

PRE on Nasdaq

Prenetics Global Ltd

Prenetics Global Ltd is a pharmaceutical preparations company in the Cayman Islands.1 It is headquartered in Quarry Bay, Hong Kong.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with CAPRICOR THERAPEUTICS, INC., NextCure, Inc. or NewAmsterdam Pharma Co N.V., or pick any stock.

  • TickerPRE on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersQuarry Bay, Hong Kong1
  • Incorporated inCayman Islands2
  • Business address7/F, K11 Atelier, 728 King'S Road, Quarry Bay, K3 0000002
  • Filer categoryNon-accelerated filer, Emerging growth company2

See how the biggest companies compare on our leaderboards

IM8 is the flagship brand of Prenetics. Prenetics was founded in 2014 in Hong Kong by Danny Yeung and has evolved—through a series of deliberate strategic pivots—from a genomic testing company into a consumer health and longevity platform. IM8 was co-founded with David Beckham and launched in December 2024. Its performance in FY2025 accelerated a strategic conclusion: Prenetics would become a consumer health company, and IM8 would be its engine.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

40.6%Gross margin4
-238.7%Operating margin4
-297.9%Net margin4
65.2%Revenue growth, 20235
-30.8%Return on equity4
-$14.1MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue52¢$12.9M
  • Research and development47¢$11.7M
  • Income tax1¢$269.0K

Out of $21.7M in revenue.54 The company lost money this year.

Financial statements

Revenue65$21.7M in 2023−67% since 2020
0$20.0M$40.0M$60.0M$80.0M2020: $65.2M$65.2M20202021: $12.5M$12.5M2021−81%2022: $13.2M$13.2M2022+5%2023: $21.7M$21.7M2023+65%
Gross profit654$8.8M in 2023−66% since 2020
0$10.0M$20.0M$30.0M2020: $26.3M$26.3M20202021: $3.6M$3.6M2021−86%2022: $3.6M$3.6M2022+0%2023: $8.8M$8.8M2023+144%
Operating income654-$51.9M in 2023+5116% since 2020
-$80.0M-$60.0M-$40.0M-$20.0M02020: -$995.1K-$995.1K20202021: -$56.7M-$56.7M2021+5594%2022: -$66.0M-$66.0M2022+17%2023: -$51.9M-$51.9M2023−21%
Net income654-$64.8M in 2023+3198% since 2020
-$200.0M-$150.0M-$100.0M-$50.0M02020: -$2.0M-$2.0M20202021: -$174.0M-$174.0M2021+8761%2022: -$190.5M-$190.5M2022+9%2023: -$64.8M-$64.8M2023−66%
Fiscal year20192020202120222023
Revenue$65.2M6$12.5M5$13.2M5$21.7M5
Cost of revenue$8.9M5$9.5M4$12.9M4
Gross profit$26.3M6$3.6M5$3.6M4$8.8M4
Research and development$6.4M5$6.0M4$11.7M4
Operating income-$995.1K6-$56.7M5-$66.0M4-$51.9M4
Interest$5.2M6$4.2M6
Income before tax-$216.6M5-$225.8M4-$56.7M4
Income tax$2.6M5-$245.0K4-$269.0K4
Net income-$2.0M6-$174.0M5-$190.5M4-$64.8M4
Earnings per share-$0.156-$178.815-$37.574-$5.584
Earnings per share (diluted)-$0.156-$178.815-$37.574-$5.584
Shares (weighted, basic)973.1K shares55.1M shares411.2M shares4
Shares (weighted, diluted)5.1M shares411.2M shares4

Compare Prenetics Global Ltd with another company

Corporate structure

Prenetics Global Ltd sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Prenetics Global Ltd

  • Genetel Bioventures Ltd Filed SCHEDULE 13G/A on Prenetics Global Ltd, latest Apr 22, 2026 (3 filings since Aug 17, 2022)
  • EASTSPRING INVESTMENTS (SINGAPORE) LTD Filed SCHEDULE 13G/A on Prenetics Global Ltd, latest Nov 7, 2024 (4 filings since Jun 8, 2022)
  • Pacific Alliance Group Ltd Filed SC 13G/A on Prenetics Global Ltd, latest Nov 27, 2023 (2 filings since May 31, 2022)
  • Dennis Yuk Ming Lo Filed SC 13D on Prenetics Global Ltd, latest Aug 7, 2023
  • Danny Sheng Wu Yeung Filed SC 13D/A on Prenetics Global Ltd, latest Jul 25, 2023 (3 filings since May 31, 2022)
  • Chi Hung Lawrence Tzang Filed SC 13D on Prenetics Global Ltd, latest Mar 27, 2023
  • Artisan LLC Filed SC 13G/A on Prenetics Global Ltd, latest Nov 25, 2022 (2 filings since May 31, 2022)
  • Chi Kong Cheng Filed SC 13G on Prenetics Global Ltd, latest Jun 29, 2022
  • Aspex Management (HK) Ltd Filed SC 13G on Prenetics Global Ltd, latest May 27, 2022
  • Prenetics Global Ltd Quarry Bay, Hong Kong

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Prenetics Global Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$52.3M4 Dec 31, 2024$45.7M4 Dec 31, 2023+14.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$37.4M4 Dec 31, 2024$29.2M4 Dec 31, 2023+28.1%
Intangible assets, net (excluding goodwill)$11.6M4 Dec 31, 2024$13.4M4 Dec 31, 2023−13.8%

Inventory

ItemLatestA year beforeChange
Inventory, total$6.6M4 Dec 31, 2024$3.1M4 Dec 31, 2023+110.0%

Leadership

Who has led Prenetics Global Ltd, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Danny Sheng Wu Yeung2026–now

Chief financial officer

  1. Hoi Chun Lo2026
  2. Brian J. Rosin2026–now
Board members and other officers (7)

Timeline

  1. Mar 30, 2026New chief executive Danny Sheng Wu Yeung becomes CEO7

Calendar

Coming up

  1. Nov 9, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($0.41) a share, on Nov 10, 2025.16

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

244 filings to the SEC since October 2021: 9 annual reports, 23 insider forms, 18 large holders, 194 other. The latest 20:

  1. Oct 13, 20266-K EDGAR
  2. Oct 6, 20264 EDGAR
  3. Oct 2, 20264 EDGAR
  4. Sep 22, 2026F-1/A EDGAR
  5. Sep 8, 2026F-1/A EDGAR
  6. Sep 4, 202620-F/A EDGAR
  7. Sep 4, 20264 EDGAR
  8. Sep 4, 20264 EDGAR
  9. Aug 26, 20266-K EDGAR
  10. Aug 26, 20264 EDGAR
  11. Aug 26, 20263 EDGAR
  12. Aug 24, 20264 EDGAR
  13. Aug 24, 20264 EDGAR
  14. Aug 21, 2026S-8 EDGAR
  15. Aug 20, 20266-K EDGAR
  16. Aug 18, 20266-K EDGAR
  17. Aug 17, 20266-K EDGAR
  18. Aug 12, 20263 EDGAR
  19. Aug 7, 2026F-1/A EDGAR
  20. Aug 7, 20266-K EDGAR

The 244 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

4 open-market trades by officers, directors and large owners since October 2021: 4 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 25, 2026Rosin Brian JCFO of IM8 (US) LLCBuy5,100$22.80$116.3KForm 4
Aug 24, 2026Rosin Brian JCFO of IM8 (US) LLCBuy18,000$21.19$381.4KForm 4
Aug 24, 2026Yeung Danny Sheng WuChief Executive OfficerBuy17,181$21.23$364.7KForm 4
Aug 20, 2026Yeung Danny Sheng WuChief Executive OfficerBuy7,500$18.31$137.3KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Prenetics Global Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARPrenetics Global Ltd1
  • CIK0001876431
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company3
  • Incorporated inCayman Islands3
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address7/F, K11 Atelier, 728 King'S Road, Quarry Bay, K3 0000001
  • Phone(852) 2210-71881
  • Shares outstanding16,874,089 shares as of Dec 31, 20253
  • AuditorDeloitte Touche Tohmatsu, Hong Kong PCAOB ID 1104; no auditor attestation of internal control over financial reporting3
  • On EDGAR sinceSep 16, 20211
  • Filings267 in all: 6-K (76), 425 (29), CORRESP (27), UPLOAD (20), 4 (13), 3 (9), F-4/A (9), 424B3 (7)1
    All 33 form types

    EFFECT (7), 6-K/A (6), F-1/A (6), SC 13G (6), 20-F (5), POS AM (5), S-8 (5), SC 13G/A (5), 20-F/A (4), F-3 (4), F-3/A (3), SC 13D (3), 424B5 (2), RW (2), SC 13D/A (2), SCHEDULE 13G/A (2), SEC STAFF LETTER (2), 20FR12B (1), 3/A (1), 8-A12B (1), CERT (1), DRS (1), DRSLTR (1), F-1 (1), F-4 (1)

  • Latest filingsAnnual report (20-F) Apr 30, 2026

Securities registered for trading

ClassSymbolExchange
Class A Ordinary Shares, par value $0.0015 per sharePREThe Nasdaq Stock Market LLC
WarrantsPRENWThe Nasdaq Stock Market LLC

From the cover page of the 20-F filed Apr 30, 2026 (Section 12(b) of the Exchange Act).3

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25